Finally, we tested the peptibodyF4_1-vcMMAE conjugate for its ability to specifically deliver drug to FGFR1 positive cancer cell lines as the ultimate prerequisite for cytotoxic peptibody conjugates is their ability to cause cell toxicity dependent on the presence of molecular target, in our case, FGFR1. This evidence concerns the gene FGFR1 and cancer.